| Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut P Praveschotinunt, AM Duraj-Thatte, I Gelfat, F Bahl, DB Chou, NS Joshi Nature communications 10 (1), 5580, 2019 | 252 | 2019 |
| Superparamagnetic iron oxide-encapsulating polymersome nanocarriers for biofilm eradication BM Geilich, I Gelfat, S Sridhar, AL van de Ven, TJ Webster Biomaterials 119, 78-85, 2017 | 173 | 2017 |
| Plasmid Vectors for in Vivo Selection-Free Use with the Probiotic E. coli Nissle 1917 A Kan, I Gelfat, S Emani, P Praveschotinunt, NS Joshi ACS synthetic biology 10 (1), 94-106, 2020 | 39 | 2020 |
| Fructose-enhanced antimicrobial activity of silver nanoparticle-embedded polymersome nanocarriers I Gelfat, BM Geilich, TJ Webster Journal of Biomedical Nanotechnology 14 (3), 619-626, 2018 | 8 | 2018 |
| Single domain antibodies against enteric pathogen virulence factors are active as curli fiber fusions on probiotic E. coli Nissle 1917 I Gelfat, Y Aqeel, JM Tremblay, JJ Jaskiewicz, A Shrestha, JN Lee, S Hu, ... PLoS Pathogens 18 (9), e1010713, 2022 | 7 | 2022 |
| Probiotic associated therapeutic curli hybrids (PATCH) P Praveschotinunt, AM Duraj-Thatte, I Gelfat, F Bahl, DB Chou, NS Joshi BioRxiv, 464966, 2018 | 1 | 2018 |
| Engineering E. coli Nissle 1917 to Advance and Facilitate Its Use in Biomedical Applications I Gelfat Harvard University, 2021 | | 2021 |
| Engineering Living Materials: Designing Biological Cells as Nanomaterials Factories PQ Nguyen, P Praveschotinunt, A Manjula-Basavanna, I Gelfat, NS Joshi 21st Century Nanoscience–A Handbook, 8-1-8-11, 2020 | | 2020 |
| Exploring microbial engineering for enhanced mucosal healing in inflammatory bowel disease P Praveschotinunt, AM Duraj-Thatte, I Gelfat Inflammatory bowel diseases (IBD) 13336, 6, 0 | | |
| Plasmid vectors for in vivo selection‐free use with the probiotic E. coli Nissle A Kan, I Gelfat, S Emani, P Praveschotinunt, NS Joshi | | |
Neel JoshiNortheastern UniversityVerified email at northeastern.edu
